Here is a fact that should reframe how you think about Insmed (NASDAQ:INSM) and its lung disease franchise: Japan has more ...

Four types of lung cells — including immune cells — function together on a chip environment that simulates respiration and ...

Truist has a ‘Buy’ rating on the shares with a price target of $205, representing a potential upside of about 51% from Friday ...

The biopharma company will now seek Arikayce’s approval in the US and Japan for use in earlier lines of treatment.

Neutrophil infiltration is a hallmark of pulmonary inflammation during respiratory viral infections, yet the origin of these ...

Insmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung ...

A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists ...

Even after completing treatment for tuberculosis (TB), some patients may remain vulnerable to further lung infections.

Please provide your email address to receive an email when new articles are posted on . RA-ILD was associated with an increased risk for infection vs. RA without lung disease. RA-associated ...

Millions of people living with lung conditions face heightened health risks this winter due to persistent wet weather and the ...

After lung transplantation, infection with Pseudomonas aeruginosa independently predicted antibody-mediated rejection (AMR), researchers found. Through a series of mouse-model studies, the researchers ...